the Effects of Cerebral Collateral Circulation on the Outcome of Leukoaraiosis in High-risk Population
NCT ID: NCT03246373
Last Updated: 2020-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1037 participants
OBSERVATIONAL
2017-10-11
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRSI Evaluation for Minor Stroke With Large Vessel Occlusion
NCT06457217
Prognosis in Subacute Ischemic Stroke Using Multimodal Imaging
NCT06289036
A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic Stroke
NCT06077305
Effects of Limb Ischemic Postconditioning in Young sICAS
NCT02323425
Stroke Imaging Package Study
NCT02485275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. The clinical trial team meets once a week to monitor the quality of clinical trials.
3. The severity of the leukoaraiosis will be evaluated by a scale. The patients whose score is more than 2 will take additional magnetic resonance examination including magnetic resonance angiography (MRA) and arterial spin labeling (ASL). And their cognitive ability will be evaluated by a series of scales including Mini-Mental State Examination (MMSE) and Montreal cognitive assessment (MoCA) and gait by the short physical performance battery (SPPB).
The blood sample will be taken for biochemical detection and hair and nail samples for trace element detection.
4. Data were analyzed by regression analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The MRI scale score ≥ 2
Exclusion Criteria
* History of malignant tumor
* History of connective tissue disease
* Pregnant, trying to become pregnant or within 6 weeks after delivery
* serious infections
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xin Wang
Role: PRINCIPAL_INVESTIGATOR
neurology department of Zhongshan hospital, Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
neurology department of Zhongshan hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Jing Ding
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSA2016KY001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.